The copper binding properties of metformin - QCM-D, XPS and nanobead agglomeration

  • Xueling Quan
  • , Rokon Uddin
  • , Arto Heiskanen
  • , Mattias Parmvi
  • , Katharina Nilson
  • , Marco Donolato
  • , Mikkel Fougt Hansen
  • , Graham Rena
  • , Anja Boisen

    Research output: Contribution to journalJournal articleResearchpeer-review

    676 Downloads (Orbit)

    Abstract

    Study of the copper binding properties of metformin is important for revealing its mechanism of action as a first-line type-2 diabetes drug. A quantitative investigation of interactions between metformin and l-cysteine-copper complexes was performed. The results suggest that metformin could interact with biological copper, which plays a key role in mitochondrial function.
    Original languageEnglish
    JournalChemical Communications
    Volume51
    Issue number97
    Pages (from-to)17313-17316
    ISSN1359-7345
    DOIs
    Publication statusPublished - 2015

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'The copper binding properties of metformin - QCM-D, XPS and nanobead agglomeration'. Together they form a unique fingerprint.

    Cite this